Security
GWPH · GW PHARMACEUTICALS PLC
GWPHNASDAQotherHistorical · closed May 4, 2021CIK 1351288Updated Sep 26, 2026
GWPH price & chart
Historical security
This listing closed May 4, 2021. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Financials
FY 2020 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|
| ASSETS | |||
| AssetsUSD | 939,511,000Source | 882,249,000Source | 756,068,000Source |
| Property, Plant and Equipment, NetUSD | 143,767,000Source | 127,765,000Source | 90,832,000Source |
| GoodwillUSD | 6,959,000Source | 6,959,000Source | 6,959,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 5,565,000Source | — | — |
| Current assets: | |||
| Cash and Cash Equivalents, at Carrying ValueUSD | 486,752,000Source | 536,933,000Source | 591,497,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 71,168,000Source | 48,883,000Source | 4,192,000Source |
| Inventory, NetUSD | 129,138,000Source | 85,528,000Source | 33,030,000Source |
| Assets, CurrentUSD | 729,530,000Source | 699,636,000Source | 646,622,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 42,472,000Source | 28,292,000Source | 17,903,000Source |
| Operating Lease, Right-of-Use AssetUSD | 25,118,000Source | 24,916,000Source | — |
| Other Assets, NoncurrentUSD | 7,795,000Source | 4,850,000Source | 2,935,000Source |
| LIABILITIES AND EQUITY | |||
| LiabilitiesUSD | 198,421,000Source | 156,215,000Source | 81,988,000Source |
| Stockholders’ equity: | |||
| Common Stock, Value, IssuedUSD | 577,000Source | 570,000Source | 564,000Source |
| Retained Earnings (Accumulated Deficit)USD | -896,087,000Source | -837,959,000Source | -828,940,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -53,551,000Source | -68,623,000Source | -78,688,000Source |
| Stockholders' Equity Attributable to ParentUSD | 741,090,000Source | 726,034,000Source | 674,080,000Source |
| Additional Paid in Capital, Common StockUSD | 1,690,151,000Source | 1,632,046,000Source | 1,581,144,000Source |
| Liabilities and EquityUSD | 939,511,000Source | 882,249,000Source | 756,068,000Source |
| Current liabilities: | |||
| Liabilities, CurrentUSD | 159,806,000Source | 117,561,000Source | 66,216,000Source |
| Operating Lease, Liability, CurrentUSD | 6,209,000Source | 5,902,000Source | — |
| Accounts Payable, CurrentUSD | 21,870,000Source | 9,990,000Source | 9,796,000Source |
| Operating Lease, Liability, NoncurrentUSD | 22,127,000Source | 21,650,000Source | — |
| Other Liabilities, NoncurrentUSD | 11,034,000Source | 11,431,000Source | 10,082,000Source |
| Additional Financial Items | |||
| Accrued Liabilities, CurrentUSD | 127,849,000Source | 99,374,000Source | 52,477,000Source |
cash flow · annual statements
| Line item | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -58,128,000Source | -9,019,000Source | -295,167,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation, Depletion and AmortizationUSD | 12,757,000Source | 9,240,000Source | 9,290,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 58,359,000Source | 48,030,000Source | 31,627,000Source |
| Changes in operating assets and liabilities: | |||
| Increase (Decrease) in Accounts ReceivableUSD | 22,104,000Source | 44,623,000Source | 804,000Source |
| Increase (Decrease) in InventoriesUSD | 39,873,000Source | 51,125,000Source | 13,646,000Source |
| Increase (Decrease) in Accounts PayableUSD | 9,862,000Source | 805,000Source | 2,238,000Source |
| Deferred Income Tax Expense (Benefit)USD | -2,669,000Source | -9,698,000Source | -317,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -27,385,000Source | -123,469,000Source | -231,868,000Source |
| Cash flows from investing activities: | |||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -28,007,000Source | 61,629,000Source | -32,887,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 18,585,000Source | 40,386,000Source | 31,362,000Source |
| Cash flows from financing activities: | |||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 1,826,000Source | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -1,129,000Source | 1,946,000Source | 297,754,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -50,181,000Source | -54,564,000Source | 32,759,000Source |
| Supplemental disclosure of cash flow information: | |||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 1,121,000Source | 1,087,000Source | 1,249,000Source |
| Income Taxes Paid, NetUSD | 9,139,000Source | 10,462,000Source | 3,726,000Source |
| Additional Financial Items | |||
| Share-based Payment Arrangement, ExpenseUSD | 54,983,000Source | 45,225,000Source | 31,627,000Source |
| DepreciationUSD | 9,900,000Source | 8,000,000Source | 8,500,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -3,974,000Source | -2,272,000Source | -4,963,000Source |
| Gain (Loss) on Disposition of Intangible AssetsUSD | — | 104,117,000Source | — |
| GoodwillUSD | 6,959,000Source | 6,959,000Source | 6,959,000Source |
| Income Tax Expense (Benefit)USD | 3,082,000Source | -184,000Source | 3,797,000Source |
| Investment Income, InterestUSD | 1,814,000Source | 8,464,000Source | 3,645,000Source |
| Net Income (Loss) Attributable to ParentUSD | -58,128,000Source | -9,019,000Source | -295,167,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | 297,931,000Source |
| Proceeds from Stock Options ExercisedUSD | 1,579,000Source | 2,878,000Source | 621,000Source |
income statement · annual statements
| Line item | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|
| Total RevenueUSD | 527,205,000Source | 311,332,000Source | 12,737,000Source |
| Cost of RevenueUSD | 37,531,000Source | 27,199,000Source | 5,986,000Source |
| Gross Profit (Calculated) · Derived | — | — | — |
| Selling, General and Administrative ExpenseUSD | 336,043,000Source | 259,880,000Source | 141,818,000Source |
| Operating Income (Loss)USD | -51,765,000Source | -118,425,000Source | -288,803,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -55,046,000Source | -9,203,000Source | -291,370,000Source |
| Income Tax Expense (Benefit)USD | 3,082,000Source | -184,000Source | 3,797,000Source |
| Net Income (Loss) Attributable to ParentUSD | -58,128,000Source | -9,019,000Source | -295,167,000Source |
| Additional Financial Items | |||
| Costs and ExpensesUSD | 578,970,000Source | 429,757,000Source | 301,540,000Source |
| Current Income Tax Expense (Benefit)USD | 5,751,000Source | 9,514,000Source | 4,114,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -3,974,000Source | -2,272,000Source | -4,963,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 32,183,000Source | 22,822,000Source | 12,041,000Source |
| Interest ExpenseUSD | 1,121,000Source | 1,087,000Source | 1,249,000Source |
| Investment Income, InterestUSD | 1,814,000Source | 8,464,000Source | 3,645,000Source |
| Research and Development ExpenseUSD | 205,396,000Source | 142,678,000Source | 153,736,000Source |